Coelho Rogerio Vivaldi Insider Trading $ONCE Spark Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Coelho Rogerio Vivaldi.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Coelho Rogerio Vivaldi. Coelho Rogerio Vivaldi is Chief Commercial Officer in Spark Therapeutics, Inc. ($ONCE) and EVP, Chief Global Therapeutics in Bioverativ Inc. ($BIVV) and President and CEO in Sigilon Therapeutics, Inc. ($SGTX).

Coelho Rogerio Vivaldi in Spark Therapeutics, Inc.

Trading Symbol: ONCE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Coelho Rogerio Vivaldi: Chief Commercial Officer
Holdings: 19,716 shares
Current Value: $1,243,291
Latest Transaction: Jul 19 2016
$ONCE Market Capitalization: $2.00B
$ONCE Previous Close: $63.06

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Coelho Rogerio Vivaldi in Spark Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BIVV, SGTX, ONCE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 19 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM7.505,00037,500155,186
Jul 19 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM3.451,0003,45010,203
Jul 19 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM3.451,0003,4509,116
Jul 19 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...SellS53.321,40074,64818,71620.1 K to 18.7 K (-6.96 %)
Jul 19 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...SellS52.965,600296,57620,11625.7 K to 20.1 K (-21.78 %)
Jul 19 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...BuyM7.505,00037,50025,71620.7 K to 25.7 K (+24.14 %)
Jul 19 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...BuyM3.451,0003,45020,71619.7 K to 20.7 K (+5.07 %)
Jul 19 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...BuyM3.451,0003,45019,71618.7 K to 19.7 K (+5.34 %)
Apr 22 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM7.502001,500160,186
Apr 22 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM3.451,0003,45010,116
Apr 22 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM7.504,80036,000160,386
Apr 22 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM3.451,0003,45011,203
Apr 22 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...SellS40.021,20048,02418,71619.9 K to 18.7 K (-6.03 %)
Apr 22 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...BuyM7.502001,50019,91619.7 K to 19.9 K (+1.01 %)
Apr 22 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...BuyM3.451,0003,45019,71618.7 K to 19.7 K (+5.34 %)
Apr 22 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...SellS40.025,800232,11618,71624.5 K to 18.7 K (-23.66 %)
Apr 22 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...BuyM7.504,80036,00024,51619.7 K to 24.5 K (+24.35 %)
Apr 22 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...BuyM3.451,0003,45019,71618.7 K to 19.7 K (+5.34 %)
Jan 07 2016ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseA40.4455,0002,224,20055,000
Oct 14 2015ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM7.5037,333279,998165,186
Oct 14 2015ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...SellS48.1524,0001,155,60018,71642.7 K to 18.7 K (-56.19 %)
Oct 14 2015ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...BuyM7.5037,333279,99842,7165.4 K to 42.7 K (+693.54 %)
Oct 09 2015ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM7.5030,000225,000202,519
Oct 09 2015ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM3.455,00017,25012,203
Oct 09 2015ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...Option ExerciseM3.455,00017,25011,116
Oct 09 2015ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...SellS50.401,00050,4005,3836.4 K to 5.4 K (-15.67 %)
Oct 09 2015ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...SellS48.8140,0001,952,4006,38346.4 K to 6.4 K (-86.24 %)
Oct 09 2015ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...BuyM7.5030,000225,00046,38316.4 K to 46.4 K (+183.12 %)
Oct 09 2015ONCESpark Therapeutics ...Vivaldi Coelho RogerioChief Commercial Of ...BuyM3.4510,00034,50016,3836.4 K to 16.4 K (+156.67 %)

Page:   1